JASPER THERAPEUTICS INC - COM (JSPR)

CUSIP: 471871103

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
10,298,176
Share change
+10,298,176
Total reported value
$101,404,000
Price per share
$10.26
Number of holders
9
Value change
+$101,404,000
Number of buys
9

Quarterly Holders Quick Answers

What is CUSIP 471871103?
CUSIP 471871103 identifies JSPR - JASPER THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of JASPER THERAPEUTICS INC - COM (JSPR) as of Q3 2021

As of 30 Sep 2021, JASPER THERAPEUTICS INC - COM (JSPR) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,298,176 shares. The largest 9 holders included Abingworth LLP, CITADEL ADVISORS LLC, FEDERATED HERMES, INC., MORGAN STANLEY, JANE STREET GROUP, LLC, Tudor Investment Corp Et Al, Tower Research Capital LLC (TRC), UBS Group AG, and ROYAL BANK OF CANADA. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.